Pharmaceutical regulation in Europe and its impact on corporate R&D
Pharmaceutical regulation in Europe and its impact on corporate R&D is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pharmaceutical regulation in Europe and its impact on corporate R&D have?
Pharmaceutical regulation in Europe and its impact on corporate R&D has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Pharmaceutical regulation in Europe and its impact on corporate R&D published?
Pharmaceutical regulation in Europe and its impact on corporate R&D has 2014 year in the ScholarIQ index.
What is the open-access status of Pharmaceutical regulation in Europe and its impact on corporate R&D?
Pharmaceutical regulation in Europe and its impact on corporate R&D has gold oa status in the ScholarIQ index.
What is the DOI of Pharmaceutical regulation in Europe and its impact on corporate R&D?
The DOI for Pharmaceutical regulation in Europe and its impact on corporate R&D is on the source record.
What is the PMID of Pharmaceutical regulation in Europe and its impact on corporate R&D?
The PMID for Pharmaceutical regulation in Europe and its impact on corporate R&D is on the source record.
What is the OpenAlex record for Pharmaceutical regulation in Europe and its impact on corporate R&D?
The OpenAlex for Pharmaceutical regulation in Europe and its impact on corporate R&D is on the source record.